Annual Cash & Cash Equivalents
$93.11 M
+$49.53 M+113.63%
31 December 2023
Summary:
Eliem Therapeutics annual cash & cash equivalents is currently $93.11 million, with the most recent change of +$49.53 million (+113.63%) on 31 December 2023. During the last 3 years, it has risen by +$72.63 million (+354.49%). ELYM annual cash & cash equivalents is now at all-time high.ELYM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$146.18 M
-$76.97 M-34.49%
30 September 2024
Summary:
Eliem Therapeutics quarterly cash and cash equivalents is currently $146.18 million, with the most recent change of -$76.97 million (-34.49%) on 30 September 2024. Over the past year, it has increased by +$88.82 million (+154.87%). ELYM quarterly cash and cash equivalents is now -34.49% below its all-time high of $223.14 million, reached on 30 June 2024.ELYM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELYM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +113.6% | +154.9% |
| 3 y3 years | +354.5% | +132.7% |
| 5 y5 years | - | - |
ELYM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +354.5% | -34.5% | +477.9% |
| 5 y | 5 years | at high | +354.5% | -34.5% | +613.5% |
| alltime | all time | at high | +354.5% | -34.5% | +613.5% |
Eliem Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $146.18 M(-34.5%) |
| June 2024 | - | $223.14 M(+112.5%) |
| Mar 2024 | - | $105.03 M(+12.8%) |
| Dec 2023 | $93.11 M(+113.6%) | $93.11 M(+62.3%) |
| Sept 2023 | - | $57.35 M(+126.7%) |
| June 2023 | - | $25.29 M(-26.5%) |
| Mar 2023 | - | $34.44 M(-21.0%) |
| Dec 2022 | $43.59 M | $43.59 M(+21.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $35.94 M(+10.3%) |
| June 2022 | - | $32.60 M(+2.1%) |
| Mar 2022 | - | $31.93 M(-31.9%) |
| Dec 2021 | $46.92 M(+129.0%) | $46.92 M(-25.3%) |
| Sept 2021 | - | $62.82 M(-36.9%) |
| June 2021 | - | $99.48 M(+107.6%) |
| Mar 2021 | - | $47.91 M(+133.9%) |
| Dec 2020 | $20.49 M(-3.5%) | $20.49 M |
| Dec 2019 | $21.22 M | - |
FAQ
- What is Eliem Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Eliem Therapeutics?
- What is Eliem Therapeutics annual cash & cash equivalents year-on-year change?
- What is Eliem Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Eliem Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ELYM is $93.11 M
What is the all time high annual cash & cash equivalents for Eliem Therapeutics?
Eliem Therapeutics all-time high annual cash & cash equivalents is $93.11 M
What is Eliem Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ELYM annual cash & cash equivalents has changed by +$49.53 M (+113.63%)
What is Eliem Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ELYM is $146.18 M
What is the all time high quarterly cash and cash equivalents for Eliem Therapeutics?
Eliem Therapeutics all-time high quarterly cash and cash equivalents is $223.14 M
What is Eliem Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ELYM quarterly cash and cash equivalents has changed by +$88.82 M (+154.87%)